HSBC Holdings’s GSK GSK Stock Holding History

HSBC Holdings’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$400K	Buy	7,301 +1,626	+29%	+$88.1K	﹤0.01%	2319
2025 Q4	$278K	Sell	5,675 -769	-12%	-$35.9K	﹤0.01%	2556
2025 Q3	$277K	Buy	6,444 +914	+17%	+$35.7K	﹤0.01%	2360
2025 Q2	$213K	Buy	+5,530	New	+$211K	﹤0.01%	2645
2025 Q1	–	Sell	-11,182	Closed	-$378K	–	3131
2024 Q4	$378K	Sell	11,182 -2,546,222	-100%	-$91.7M	﹤0.01%	2349
2024 Q3	$104M	Sell	2,557,404 -994,715	-28%	-$40.7M	0.06%	296
2024 Q2	$138M	Sell	3,552,119 -220,909	-6%	-$9.29M	0.08%	217
2024 Q1	$162M	Buy	3,773,028 +1,277,932	+51%	+$52.7M	0.11%	177
2023 Q4	$92.3M	Buy	+2,495,096	New	+$89.6M	0.08%	248
2023 Q3	–	Sell	-6,316	Closed	-$224K	–	2766
2023 Q2	$224K	Sell	6,316 -7,766	-55%	-$279K	﹤0.01%	2277
2023 Q1	$499K	Sell	14,082 -1,011	-7%	-$35.4K	﹤0.01%	2046
2022 Q4	$527K	Sell	15,093 -60,823	-80%	-$2.03M	﹤0.01%	2267
2022 Q3	$2.24M	Buy	75,916 +67,112	+762%	+$2.54M	﹤0.01%	1512
2022 Q2	$478K	Sell	8,804 -30,487	-78%	-$1.68M	﹤0.01%	2355
2022 Q1	$2.15M	Sell	39,291 -5,721	-13%	-$311K	﹤0.01%	1572
2021 Q4	$2.49M	Sell	45,012 -44,103	-49%	-$2.29M	﹤0.01%	1590
2021 Q3	$4.26M	Buy	89,115 +33,585	+60%	+$1.69M	﹤0.01%	1206
2021 Q2	$2.77M	Buy	55,530 +44,337	+396%	+$2.13M	﹤0.01%	1313
2021 Q1	$500K	Sell	11,193 -7,533	-40%	-$342K	﹤0.01%	1970
2020 Q4	$861K	Sell	18,726 -8,136	-30%	-$374K	﹤0.01%	1801
2020 Q3	$1.26M	Sell	26,862 -7,626	-22%	-$382K	﹤0.01%	1449
2020 Q2	$1.76M	Sell	34,488 -16,790	-33%	-$861K	﹤0.01%	1207
2020 Q1	$2.42M	Buy	51,278 +14,480	+39%	+$772K	0.01%	1095
2019 Q4	$2.18M	Sell	36,798 -15,817	-30%	-$880K	﹤0.01%	1467
2019 Q3	$2.81M	Sell	52,615 -85,827	-62%	-$4.42M	0.01%	1445
2019 Q2	$6.92M	Sell	138,442 -292,012	-68%	-$14.7M	0.01%	1009
2019 Q1	$22.5M	Buy	430,454 +282,120	+190%	+$14.1M	0.04%	472
2018 Q4	$7.1M	Buy	148,334 +81,877	+123%	+$4.03M	0.01%	976
2018 Q3	$3.34M	Buy	66,457 +21,714	+49%	+$1.1M	0.01%	1293
2018 Q2	$2.25M	Sell	44,743 -97,203	-68%	-$4.9M	﹤0.01%	1453
2018 Q1	$6.93M	Buy	141,946 +81,404	+134%	+$3.79M	0.01%	979
2017 Q4	$2.68M	Buy	60,542 +18,464	+44%	+$853K	﹤0.01%	1013
2017 Q3	$2.13M	Buy	42,078 +7,473	+22%	+$379K	﹤0.01%	1288
2017 Q2	$1.87M	Buy	34,605 +5,770	+20%	+$308K	﹤0.01%	1286
2017 Q1	$1.52M	Sell	28,835 -8,419	-23%	-$427K	﹤0.01%	1297
2016 Q4	$1.79M	Sell	37,254 -5,169	-12%	-$255K	﹤0.01%	1238
2016 Q3	$2.29M	Sell	42,423 -1,722	-4%	-$94.4K	0.01%	1147
2016 Q2	$2.39M	Buy	44,145 +607	+1%	+$32K	0.01%	1137
2016 Q1	$2.21M	Buy	43,538 +7,493	+21%	+$373K	0.01%	1127
2015 Q4	$1.82M	Sell	36,045 -127,317	-78%	-$6.49M	﹤0.01%	1283
2015 Q3	$7.85M	Buy	163,362 +141,082	+633%	+$7.34M	0.02%	675
2015 Q2	$1.16M	Buy	22,280 +14,783	+197%	+$832K	﹤0.01%	1204
2015 Q1	$432K	Sell	7,497 -3,215	-30%	-$184K	﹤0.01%	1604
2014 Q4	$572K	Buy	10,712 +3,690	+53%	+$206K	﹤0.01%	1456
2014 Q3	$404K	Buy	7,022 +4,025	+134%	+$247K	﹤0.01%	1511
2014 Q2	$200K	Sell	2,997 -405	-12%	-$27.4K	﹤0.01%	1698
2014 Q1	$227K	Sell	3,402 -3,068	-47%	-$207K	﹤0.01%	1598
2013 Q4	$432K	Sell	6,470 -157	-2%	-$10.2K	﹤0.01%	1463
2013 Q3	$415K	Buy	6,627 +337	+5%	+$21.7K	﹤0.01%	1432
2013 Q2	$392K	Buy	+6,290	New	+$399K	﹤0.01%	1252

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

HSBC Holdings's GSK Position: Q1 2026 in Review

HSBC Holdings increased its GSK (GSK) stake by 29% in Q1 2026, buying an estimated $88.1K and bringing the position to 7,301 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #2319.

HSBC Holdings first reported a position in GSK in Q2 2013 and has held it in 50 quarters since. The position peaked at $162M in Q1 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

HSBC Holdings held 7,301 shares of GSK worth $400K as of Q1 2026.
HSBC Holdings bought 1,626 GSK shares in Q1 2026, an estimated $88.1K.
GSK made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2319 holding.
HSBC Holdings first reported a position in GSK in Q2 2013 and has held it in 50 quarters since.
HSBC Holdings's GSK position peaked at $162M in Q1 2024.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.